发明名称 |
Composition containing cinchonine as an active ingredient for preventing and treating obesity, dyslipidemia, fatty liver, or insulin resistance syndrome |
摘要 |
The present invention relates to a composition for preventing or treating obesity, dyslipidemia, fatty liver or insulin resistance syndrome, comprising cinchonine as an active ingredient. The composition of the present invention comprising cinchonine as an active ingredient contributes to not only inhibition of adipocyte differentiation but also reductions of body weight, visceral fat, total cholesterol level, plasma triglyceride level and liver tissue triglyceride level, thereby exerting prevention or treatment efficacies of obesity, hyperlipidemia or fatty liver. In addition, the composition of the present invention induces significant decrease in fasting glucose level and blood insulin level to improve type 2 diabetes, insulin resistance and related metabolic diseases. |
申请公布号 |
US9040557(B2) |
申请公布日期 |
2015.05.26 |
申请号 |
US201013578717 |
申请日期 |
2010.12.14 |
申请人 |
YONSEI UNIVERSITY TECHNOLOGY HOLDINGS, INC. |
发明人 |
Park Tae Sun |
分类号 |
A61K31/4409;A61K31/47;A61K31/4709;A61K31/49;A61K31/439 |
主分类号 |
A61K31/4409 |
代理机构 |
Clark & Elbing LLP |
代理人 |
Clark & Elbing LLP |
主权项 |
1. A method for decreasing lipid levels, treating obesity, or treating fatty liver in a subject in need thereof, the method comprising administering to the subject a composition comprising cinchonine as an active ingredient. |
地址 |
Incheon KR |